As a standalone, the weight loss is more modest than GLP-1 agonists, with trial data showing around 10 to 11% body weight loss at 2.4 mg over 32 weeks
Most users complete 2 to 3 cycles per year for ongoing maintenance
Pain 11 , 72 (2015)
These dual biochemical effects make it a focal point for research on metabolic reprogramming and longevity
Some patients report changes in comfort, mobility, or recovery within the first few weeks, but results vary and should not replace diagnosis, imaging, rehab, or medical treatment
Beyond angiogenesis, BPC-157 also modulates the nitric oxide system (which plays a role in tissue protection), increases FAK-paxillin expression (involved in cell adhesion and growth), and has been shown in animal studies to reduce inflammatory cytokines